πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 115 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9808424

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9770414

Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (D

Pacira Pharmaceuticals, Inc. Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9757336

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9737483

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9737482

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9730892

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9724302

Method for formulating large diameter synthetic membrane vesicles

Pacira Pharmaceuticals, Inc. Β· Granted Tue Aug 08 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9644004

Peptide and peptidomimetic inhibitors

RA PHARMACEUTICALS, INC. Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9624182

Compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9585838

Production of multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9556133

Polycyclic LPA1 antagonist and uses thereof

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9272990

Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9260416

Heterocyclic autotaxin inhibitors and uses thereof

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9238676

Peptide and peptidomimetic inhibitors

RA PHARMACEUTICALS, INC. Β· Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9205052

Sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9192575

Sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9090573

Compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9000025

Autotaxin inhibitors and uses thereof

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8834921

Sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. Β· Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8778983

Polycyclic compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8664220

Polycyclic compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8592402

Compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8541587

Lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8455499

Alkyne antagonists of lysophosphatidic acid receptors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted